Latest / The Well-Built Life / Untangling Alcohol Withdrawal: Symptoms, Management, & Future
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:07Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple, practical habits that help you feel stronger, healthier,
- 0:17Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:22Speaker 1: and let's dive in. So, Thomas, let's kick off with
- 0:25Speaker 1: a critical public health issue that affects many people, alcohol withdrawal.
- 0:30Speaker 1: Can you break it down for us, especially for those
- 0:33Speaker 1: who might not be familiar with the term?
- 0:35Speaker 2: Absolutely, Rachel. Alcohol withdrawal is quite a complex process that
- 0:40Speaker 2: often catches people off guard. To start, heavy alcohol consumption
- 0:45Speaker 2: is typically defined as drinking 8 or more drinks per
- 0:48Speaker 2: week for women and 15 or more drinks for men.
- 0:51Speaker 2: The long-term use of alcohol can really take its toll.
- 0:55Speaker 2: basically putting the brakes on the central nervous system and
- 0:58Speaker 2: fostering an inhibitive effect that changes brain activity.
- 1:01Speaker 1: Right, and that's the crucial nuance here. Many people think
- 1:05Speaker 1: it's just a matter of stopping drinking, but Therese, a
- 1:08Speaker 1: lot more to it. Can you elaborate on what happens
- 1:11Speaker 1: immediately after someone tries to cut back or stop?
- 1:15Speaker 2: Sure, it's interesting. When the brakes are suddenly removed, the
- 1:19Speaker 2: central nervous system goes into overdrive. Symptoms can start showing
- 1:23Speaker 2: up anywhere from a few hours up to over a
- 1:25Speaker 2: day after the last drink. These symptoms range from the
- 1:29Speaker 2: more common likes of sweating and nausea to more severe
- 1:32Speaker 2: ones like anxiety and tremors. But it's the severe symptoms
- 1:35Speaker 2: that we really need to watch out for. Hallucinations and seizures,
- 1:40Speaker 2: which can occur 24 to 48 hours post drinking.
- 1:44Speaker 1: Exactly. Which brings up an interesting contradiction. The severity of
- 1:49Speaker 1: symptoms can be life-threatening. but diagnosis isn't always straightforward. Are
- 1:55Speaker 1: there specific criteria we use to diagnose alcohol withdrawal?
- 1:59Speaker 2: Yes, there are. The Diagnostic and Statistical Manual of Mental
- 2:04Speaker 2: Disorders 5th Edition DSM-5 provides guidelines. Two or more withdrawal
- 2:11Speaker 2: symptoms must be present with a recent reduction or cessation
- 2:15Speaker 2: of alcohol consumption. It's a matter of looking at the
- 2:18Speaker 2: symptoms and their intensity. The Clinical Institute Withdrawal Assessment for
- 2:22Speaker 2: Alcohol Scale, SIWA, AR, is a handy tool for clinicians
- 2:27Speaker 2: to classify patients into different withdrawal categories.
- 2:30Speaker 1: That's a good point about the SIWA R scale. And
- 2:34Speaker 1: what about the risk factors? Are there certain people who
- 2:37Speaker 1: are more at risk for severe withdrawal?
- 2:40Speaker 2: Indeed, there are several risk factors. A history of withdrawal seizures,
- 2:45Speaker 2: long-term heavy alcohol consumption, and significant psychiatric or medical conditions
- 2:51Speaker 2: all increase the likelihood of a severe withdrawal episode. Additionally,
- 2:55Speaker 2: age over 65 and being pregnant are also significant risk factors.
- 3:00Speaker 2: It's a multifaceted issue, really.
- 3:03Speaker 1: And speaking of management, how do healthcare providers decide whether
- 3:07Speaker 1: someone with alcohol withdrawal should be treated in an outpatient
- 3:11Speaker 1: or inpatient setting?
- 3:12Speaker 2: It depends on the risk factors. Mild to moderate cases
- 3:15Speaker 2: can often be managed on an outpatient basis, as long
- 3:19Speaker 2: as there are no high risk factors present. But if
- 3:21Speaker 2: we are talking about severe withdrawal, inpatient care is necessary
- 3:25Speaker 2: to monitor and manage complications. Treatment options include benzodiazepines or
- 3:31Speaker 2: barbiturates and thiamine supplementation to prevent Wernicke encephalopathy. It's really
- 3:37Speaker 2: about making sure the patient gets the right care at
- 3:39Speaker 2: the right time.
- 3:40Speaker 1: So, let's dive into the timeline from initial alcohol cessation
- 3:44Speaker 1: to symptom presentation. What's the first thing that happens when
- 3:48Speaker 1: someone decides to cut back or stop drinking completely?
- 3:52Speaker 2: Absolutely. The moment alcohol stops flowing through the bloodstream is
- 3:56Speaker 2: a turning point. This cessation leads to a rapid decrease
- 4:00Speaker 2: in the inhibitory effects on the central nervous system, CNS,
- 4:04Speaker 2: causing a sudden hyper excitability. This is why the first
- 4:07Speaker 2: symptoms can appear just a few hours after the last drink.
- 4:10Speaker 2: Can you imagine the dramatic shift from the depressant state
- 4:13Speaker 2: to the opposite?
- 4:14Speaker 1: It's certainly a stark contrast. But what are the physiological
- 4:18Speaker 1: mechanisms at play? How does the CNS actually transition from
- 4:23Speaker 1: being heavily inhibited to hyperactive?
- 4:25Speaker 2: Great question. Essentially, alcohol acts as a glycine and GABA
- 4:30Speaker 2: receptor antagonist, meaning it inhibits the action of these neurotransmitters.
- 4:35Speaker 2: When alcohol is removed, to raise an abrupt cessation of
- 4:38Speaker 2: this inhibition. The sudden absence causes a rebound effect where
- 4:42Speaker 2: the GABA and glycine systems become overactive. This overexcitability leads
- 4:47Speaker 2: to a cascade of symptoms like tremors, anxiety, and even seizures,
- 4:51Speaker 2: especially during the early stages.
- 4:54Speaker 1: Fascinating. So, could you walk us through the sequence of
- 4:58Speaker 1: events during the transition from initial cessation to symptom presentation?
- 5:03Speaker 2: Sure. Typically, the earliest symptoms are like mild sweating and nausea,
- 5:09Speaker 2: can show up anywhere from 3 to 24 hours post.
- 5:12Speaker 2: Last drink. Within a day, symptoms like tremors and anxiety
- 5:17Speaker 2: can kick in, indicating the CNS is trying to regain balance.
- 5:21Speaker 2: By 24 to 48 hours, severe symptoms like hallucinations and
- 5:26Speaker 2: generalized tonic. Clonic seizures can manifest due to the severe
- 5:30Speaker 2: disruption in the brain's chemical equilibrium.
- 5:33Speaker 1: It's a rapid and complex process. Are there specific physiological
- 5:38Speaker 1: signs healthcare providers look for to assess the severity?
- 5:42Speaker 2: Absolutely. They monitor for signs of sympathetic overactivity, such as
- 5:47Speaker 2: tachycardia and blood pressure fluctuations. Jaundice and elevated liver function
- 5:53Speaker 2: tests are also common, reflecting the liver's struggle to detoxify itself.
- 5:58Speaker 2: And don't forget, thiamine levels can dip significantly. potentially leading
- 6:03Speaker 2: to Wernicke encephalopathy if left untreated.
- 6:06Speaker 1: That's why monitoring and managing those factors is so critical.
- 6:11Speaker 1: Speaking of management, what's the typical approach once a patient
- 6:15Speaker 1: is diagnosed with alcohol withdrawal?
- 6:17Speaker 2: It depends on the risk factors. For those with mild
- 6:20Speaker 2: to moderate symptoms, outpatient management might be sufficient. However, in
- 6:24Speaker 2: cases with high risk factors like a history of withdrawal
- 6:27Speaker 2: seizures or long-term heavy alcohol consumption, inpatient care is often necessary.
- 6:33Speaker 2: Treatment involves medications like benzodiazepines or barbiturates to stabilize the CNS,
- 6:39Speaker 2: along with thiamine supplementation to prevent Wernicke encephalopathy.
- 6:43Speaker 1: And these treatments are crucial because they can make a
- 6:46Speaker 1: big difference in patient outcomes. What do you see as
- 6:49Speaker 1: the biggest challenges in managing alcohol withdrawal?
- 6:53Speaker 2: Ethical considerations come to mind. Deciding between outpatient and inpatient
- 6:57Speaker 2: care requires balancing the patient's risks and need for support.
- 7:02Speaker 2: The choice of medication also presents a critical debate, with
- 7:05Speaker 2: each having its pros and cons. Plus, the socioeconomic background
- 7:10Speaker 2: of the patient can significantly impact whether they have access
- 7:13Speaker 2: to the right level of care, which is a major concern.
- 7:16Speaker 1: That's a lot to consider. How do healthcare providers navigate
- 7:20Speaker 1: these challenges to provide the best possible care?
- 7:23Speaker 2: It's complex. They rely on tools like the SIWA-R score
- 7:27Speaker 2: to classify severity and make informed decisions. However, it's not
- 7:32Speaker 2: always clear-cut. The subjective nature of risk assessment can sometimes
- 7:36Speaker 2: lead to misdiagnosis or overtreatment. The key is to tailor
- 7:40Speaker 2: the approach to the patient's specific needs while continuously reassessing
- 7:45Speaker 2: risks and benefits.
- 7:46Speaker 1: So, let's dive into the nitty-gritty of managing alcohol withdrawal. Thomas,
- 7:52Speaker 1: can you explain the differences between outpatient and inpatient care?
- 7:57Speaker 2: Absolutely, Rachel. Outpatient care is suitable for mild to moderate
- 8:01Speaker 2: cases where patients can be treated at home or in
- 8:04Speaker 2: a clinic and still function normally in their everyday lives. However,
- 8:09Speaker 2: inpatient care is more robust, providing 24-7 professional monitoring and support,
- 8:15Speaker 2: which is crucial for severe or complicated cases. Right.
- 8:19Speaker 1: And that's the crucial nuance here. Why does the risk
- 8:22Speaker 1: factor play such a big role in deciding between the two?
- 8:26Speaker 2: Well, it's all about mitigating risks. For outpatient care, patients
- 8:31Speaker 2: need to have a stable support system and low risk
- 8:34Speaker 2: of complications. If there are high risk factors, such as
- 8:38Speaker 2: a history of withdrawal seizures, then hospitalization is safer to
- 8:41Speaker 2: prevent catastrophic events. The CIWA, our score, as we discussed earlier,
- 8:46Speaker 2: helps in classifying patients based on their risk level.
- 8:49Speaker 1: Exactly, which brings up an interesting contradiction. With the CWA-R score,
- 8:55Speaker 1: to raise a subjective element that could affect the accuracy
- 8:59Speaker 1: of assessments. How do clinicians navigate this?
- 9:02Speaker 2: It's a tough one. Clinicians use the score as a guideline,
- 9:06Speaker 2: but also rely on their clinical judgment. There are scenarios
- 9:10Speaker 2: where the score might not fully capture the severity, especially
- 9:13Speaker 2: if the patient's symptoms are less straightforward. For instance, a
- 9:17Speaker 2: patient might deny significant withdrawal symptoms but still be on
- 9:21Speaker 2: the brink of a seizure.
- 9:22Speaker 1: That's wild when you look at the raw numbers. The
- 9:25Speaker 1: decision to switch from outpatient to inpatient can be a
- 9:27Speaker 1: life-saving one. So, what's the role of pharmacological treatments in
- 9:32Speaker 1: this process?
- 9:33Speaker 2: Pharmacological treatments are crucial. For mild withdrawal, benzodiazepines and barbiturates
- 9:38Speaker 2: can be effective, but for severe cases, a combination approach
- 9:42Speaker 2: is often needed. Thiamine supplementation is essential too, as it
- 9:46Speaker 2: helps prevent complications like Wernicke encephalopathy, which can have devastating effects.
- 9:52Speaker 1: So, you are saying that the choice of treatment is
- 9:55Speaker 1: not just about symptom relief, but also about preventing long-term damage.
- 10:00Speaker 1: That's a high-stakes decision for both the patient and the provider.
- 10:04Speaker 2: Absolutely. The debate between benzodiazepines and barbiturates goes beyond their efficacy.
- 10:11Speaker 2: Benzodiazepines have a rapid onset but can be addictive, while
- 10:15Speaker 2: barbiturates are slower but carry different adverse effects. Balancing these
- 10:20Speaker 2: needs careful consideration.
- 10:22Speaker 1: That's insightful. The ethical considerations in managing withdrawal can be
- 10:27Speaker 1: complex too, especially with populations with high risk factors. How
- 10:32Speaker 1: do providers ensure they are doing the right thing?
- 10:35Speaker 2: Ethically, the focus is on informed consent and ensuring patients
- 10:39Speaker 2: are not subjected to unnecessary treatments. Providers must educate patients
- 10:44Speaker 2: about the risks and benefits of different management strategies. ensuring
- 10:48Speaker 2: they are make choices they can live with.
- 10:50Speaker 1: And how do socioeconomic factors and access to resources factor
- 10:54Speaker 1: into all of this? For instance, a patient with limited
- 10:58Speaker 1: resources might find outpatient care more feasible, even if it's
- 11:02Speaker 1: not their best option.
- 11:03Speaker 2: You hit the nail on the head, Rachel. Socioeconomic barriers
- 11:08Speaker 2: can significantly impact treatment decisions. Ensuring equitable access to high-quality
- 11:13Speaker 2: care is a challenge, but it's essential. telemedicine, when feasible,
- 11:18Speaker 2: can bridge the gap, providing more flexible options.
- 11:21Speaker 1: It's all about making these decisions as holistic as possible.
- 11:25Speaker 1: Thank you for breaking down these complex elements, Thomas. It
- 11:29Speaker 1: really gives us a clearer picture of the management strategies
- 11:32Speaker 1: in place.
- 11:32Speaker 2: You are welcome, Rachel. It's a multifaceted issue, but having
- 11:36Speaker 2: these strategies in place can make all the difference.
- 11:39Speaker 1: As we move into the complex debate on managing alcohol withdrawal...
- 11:43Speaker 1: Let's start with the contrasting approaches of holistic and pharmacological methods. Thomas,
- 11:50Speaker 1: can you give us a brief overview of each approach
- 11:53Speaker 1: and what makes them unique?
- 11:54Speaker 2: Absolutely, Rachel. Holistic management focuses on treating the whole person,
- 12:00Speaker 2: incorporating practices like acupuncture, mindfulness, and lifestyle changes. It aims
- 12:06Speaker 2: to address not just the withdrawal symptoms but the underlying
- 12:10Speaker 2: causes of alcohol dependency. On the other hand, Pharmacological management
- 12:15Speaker 2: relies on medications like benzodiazepines, which target the symptoms directly,
- 12:20Speaker 2: usually because of their quick relief.
- 12:22Speaker 1: That's a great distinction. So, with holistic approaches, the idea
- 12:27Speaker 1: is to support the body's natural healing processes and reduce triggers. But,
- 12:32Speaker 1: at a granular level, how do these practices work to
- 12:35Speaker 1: combat withdrawal symptoms?
- 12:36Speaker 2: Mel, Rachel, let's take acupuncture as an example. Acupuncturists target
- 12:42Speaker 2: specific points in the body that are believed to influence
- 12:45Speaker 2: the central nervous system. By stimulating these points, they can
- 12:49Speaker 2: help reduce the intensity of withdrawal symptoms. Moreover, mindfulness techniques
- 12:54Speaker 2: like meditation can lower stress levels, which often exacerbate withdrawal symptoms.
- 13:00Speaker 2: The combination of these holistic methods can create a comprehensive
- 13:03Speaker 2: support system for the patient.
- 13:05Speaker 1: It's fascinating to see how interconnected the body and mind are.
- 13:11Speaker 1: Let's dive into the long-term versus short-term treatment approaches. Why
- 13:15Speaker 1: do these approaches matter? And how might they impact patient outcomes?
- 13:19Speaker 2: Great question, Rachel. The choice between long-term and short-term management
- 13:24Speaker 2: really depends on the severity of the withdrawal. Short-term approaches
- 13:27Speaker 2: are typically used for individuals with mild to moderate symptoms,
- 13:31Speaker 2: focusing on immediate relief and stabilization. But for those with
- 13:35Speaker 2: severe or complicated cases, long-term management ensures a more stable recovery.
- 13:41Speaker 2: often with a comprehensive plan that includes continuous support.
- 13:44Speaker 1: And what about alternative therapies? How do they fit into
- 13:48Speaker 1: this mix, and what's their efficacy like?
- 13:50Speaker 2: Alternative therapies can provide significant value, especially when integrated with
- 13:55Speaker 2: traditional medical care. For instance, yoga and nutritional counseling can
- 14:00Speaker 2: complement pharmacological treatments. These therapies often work by addressing the
- 14:05Speaker 2: physical and emotional aspects of withdrawal. reducing cravings, and improving
- 14:11Speaker 2: overall well-being. However, the key is finding a balance, using
- 14:15Speaker 2: these therapies as supplementary tools rather than relying solely on them.
- 14:20Speaker 1: That balance is crucial. Speaking of balances, it's interesting how
- 14:24Speaker 1: socioeconomic factors can also play a role. How do these
- 14:29Speaker 1: factors influence treatment decisions, and what's the impact on patient outcomes?
- 14:34Speaker 2: Socioeconomic barriers can significantly affect treatment choices. For instance, individuals
- 14:41Speaker 2: from lower socioeconomic backgrounds might struggle to access holistic therapies
- 14:46Speaker 2: or long-term care due to financial constraints. This can lead
- 14:50Speaker 2: to a more reliance on short-term pharmacological solutions. However, when
- 14:55Speaker 2: resources are available, a holistic approach can provide long-term benefits.
- 15:00Speaker 2: offering a sustainable recovery plan that addresses both physical and
- 15:04Speaker 2: psychological needs.
- 15:06Speaker 1: As we move forward into the future, some pressing questions
- 15:09Speaker 1: remain unanswered in alcohol withdrawal treatment. For instance, what exactly
- 15:14Speaker 1: triggers the mechanisms leading to Wernicke encephalopathy, and how can
- 15:19Speaker 1: we reliably manage this condition?
- 15:21Speaker 2: That's a crucial point, Rachel. Right now, The exact chain
- 15:25Speaker 2: of events that lead to Wernicke encephalopathy post-alcohol cessation are
- 15:30Speaker 2: still unclear. Research is focusing on how alcohol consumption depletes
- 15:35Speaker 2: thiamine levels, which in turn might trigger this neurological issue.
- 15:39Speaker 1: Exactly, which brings up an interesting contradiction. While thiamine supplementation
- 15:45Speaker 1: is crucial, Therese still no reliable biomarker to predict who
- 15:49Speaker 1: is at highest risk for developing encephalopathy. How does this
- 15:53Speaker 1: impact patient outcomes?
- 15:54Speaker 2: It does, big time. Right now, patients with a history
- 15:58Speaker 2: of withdrawal seizures are at a 21% higher risk, but
- 16:02Speaker 2: we can't say with certainty who will develop it. This
- 16:05Speaker 2: means a significant portion of patients might not receive the
- 16:08Speaker 2: necessary intervention early enough.
- 16:10Speaker 1: That's wild when you look at the raw numbers. But
- 16:13Speaker 1: let's pivot to emerging technologies. Are there any new tools
- 16:17Speaker 1: or methods that could help us better understand and manage
- 16:21Speaker 1: these withdrawal symptoms?
- 16:22Speaker 2: Absolutely. Tere's ongoing research into personalized treatment plans using AI
- 16:28Speaker 2: and machine learning to tailor pharmacological regimens based on individual
- 16:32Speaker 2: patient data. This could potentially lead to more effective and
- 16:35Speaker 2: targeted treatments.
- 16:36Speaker 1: That's promising. But what about the non-pharmacological side? Are there
- 16:42Speaker 1: any breakthroughs there that could offer practical alternatives?
- 16:45Speaker 2: Tere's been some interesting work on digital health tools and telemedicine.
- 16:50Speaker 2: These could enhance accessibility, especially in remote areas. For instance,
- 16:55Speaker 2: virtual reality exposure therapy has shown some promise in managing
- 17:00Speaker 2: anxiety and other withdrawal symptoms.
- 17:02Speaker 1: That's an exciting development. However, what about the accuracy and
- 17:06Speaker 1: reliability of the SIWA-R score? Are there any emerging issues
- 17:11Speaker 1: or improvements?
- 17:12Speaker 2: The SIWA-R score is a valuable tool, but its reliability
- 17:15Speaker 2: has been questioned. Recent studies suggest that it might not
- 17:19Speaker 2: be as accurate at predicting complications as previously thought. This
- 17:23Speaker 2: means that clinical decision-making might need an updated, more nuanced approach.
- 17:28Speaker 1: That brings us to the integration of advanced imaging techniques,
- 17:32Speaker 1: doesn't it? How could these tools help us better understand
- 17:36Speaker 1: the physiological changes associated with alcohol withdrawal?
- 17:39Speaker 2: For sure. Techniques like functional MRI and positron emission tomography
- 17:45Speaker 2: PET could provide insights into the brain's response to alcohol withdrawal.
- 17:50Speaker 2: This could help us develop more targeted interventions and better
- 17:53Speaker 2: risk stratification.
- 17:55Speaker 1: And finally, with telehealth on the rise, how can we
- 17:58Speaker 1: ensure these services are accessible to all, particularly those from
- 18:03Speaker 1: lower socioeconomic backgrounds?
- 18:05Speaker 2: That's a challenge. Ensuring equitable access to these advanced technologies
- 18:09Speaker 2: will require collaborative efforts between healthcare providers, telehealth companies, and
- 18:13Speaker 2: government policies. But with the right infrastructure and support, we
- 18:17Speaker 2: can make a difference.
- 18:18Speaker 1: That brings us to the end of today's episode. Thank
- 18:21Speaker 1: you so much for spending part of your day with me.
- 18:23Speaker 1: If you found this episode's tips helpful and want to
- 18:26Speaker 1: make sure you don't miss the next conversation, please take
- 18:29Speaker 1: a quick second to hit that subscribe or follow button
- 18:32Speaker 1: on whatever platform you are listening on. It's a completely
- 18:35Speaker 1: free way to support the show and helps more people
- 18:37Speaker 1: find us. This podcast is independently produced. So if you
- 18:41Speaker 1: are ever in a position where you would like to
- 18:43Speaker 1: help keep it running, We do accept small donations. You
- 18:47Speaker 1: can find a link right in the episode description below
- 18:50Speaker 1: to buy us a coffee or contribute what you can.
- 18:53Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 18:58Speaker 1: and we will talk again soon.